These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7922595)

  • 1. Tonic neuronal inhibition by AII revealed by iontophoretic application of Losartan, a specific antagonist of AII type-1 receptors.
    Martial FP; Thornton SN; Lienard F; Mousseau MC; Nicolaidis S
    Brain Res Bull; 1994; 34(6):533-9. PubMed ID: 7922595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of DOCA pretreatment on neuronal sensitivity and cell responsiveness to angiotensin II, in the bed nucleus of the stria terminalis in the rat.
    Liénard F; Thornton SN; Martial FP; Mousseau MC; Galaverna O; Meile MJ; Nicolaïdis S
    Regul Pept; 1996 Oct; 66(1-2):59-63. PubMed ID: 8899895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal responses to iontophoretically applied angiotensin II, losartan and aldosterone, as well as gustatory stimuli, in non-anesthetized control and desoxycorticosterone acetate-pretreated rats.
    Mousseau MC; Thornton SN; Martial FP; Lienard F; Nicolaidis S
    Regul Pept; 1996 Oct; 66(1-2):51-4. PubMed ID: 8899893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid pretreatment enhances angiotensin II-induced neuronal excitation but not salt drinking in male Fischer rats.
    Omouessi ST; Falconetti C; Chapleur M; Fernette B; Thornton SN
    J Neuroendocrinol; 2007 Feb; 19(2):109-15. PubMed ID: 17214873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term mineralocorticoid-induced changes in rat neuron properties plus interaction of aldosterone and ANG II.
    Thornton SN; Nicolaïdis S
    Am J Physiol; 1994 Feb; 266(2 Pt 2):R564-71. PubMed ID: 8141416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute sodium depletion modifies septo-preoptic neuron sensitivities to neurohormones.
    Liénard F; Galaverna O; Thornton SN; Meile MJ; Nicolaïdis S
    Brain Res; 1998 Mar; 787(1):171-4. PubMed ID: 9518596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II receptor subtype antagonists can both stimulate and inhibit salt appetite in rats.
    Liénard F; Thornton SN; Martial FP; Mousseau MC; Nicolaïdis S
    Regul Pept; 1996 Oct; 66(1-2):87-94. PubMed ID: 8899899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of losartan potassium and deoxycorticosterone acetate on tail skin temperature response to acute administration of angiotensin II.
    Fregly MJ; Rowland NE
    Pharmacol Biochem Behav; 1992 Sep; 43(1):229-33. PubMed ID: 1472262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional interaction between losartan and central tachykinin NK3 receptors in the conscious rat.
    Picard P; Chrétien L; Couture R
    Br J Pharmacol; 1995 Apr; 114(8):1563-70. PubMed ID: 7541280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
    Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
    Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
    Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
    Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
    Wienen W; Mauz AB; Van Meel JC; Entzeroth M
    Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
    Gorbea-Oppliger VJ; Melaragno MG; Potter GS; Petit RL; Fink GD
    J Pharmacol Exp Ther; 1994 Nov; 271(2):804-10. PubMed ID: 7965799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of nonpeptide angiotensin II receptor antagonists with the urate transporter in rat renal brush-border membranes.
    Edwards RM; Trizna W; Stack EJ; Weinstock J
    J Pharmacol Exp Ther; 1996 Jan; 276(1):125-9. PubMed ID: 8558420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AT1 receptors mediate the release of prostaglandins in porcine smooth muscle cells and rat astrocytes.
    Leung KH; Chang RS; Lotti VJ; Roscoe WA; Smith RD; Timmermans PB; Chiu AT
    Am J Hypertens; 1992 Sep; 5(9):648-56. PubMed ID: 1418854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor subtype that mediates the neuronal effects of angiotensin II in the rat dorsal medulla.
    Barnes KL; McQueeney AJ; Ferrario CM
    Brain Res Bull; 1993; 31(1-2):195-200. PubMed ID: 8095842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of net outward current in cultured neurons by angiotensin II: involvement of AT1 and AT2 receptors.
    Kang J; Sumners C; Posner P
    Brain Res; 1992 May; 580(1-2):317-24. PubMed ID: 1504808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
    Bunting MW; Widdop RE
    Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996.
    Kivlighn SD; Zingaro GJ; Gabel RA; Broten TP; Schorn TW; Schaffer LW; Naylor EM; Chakravarty PK; Patchett AA; Greenlee WJ
    Am J Hypertens; 1995 Jan; 8(1):58-66. PubMed ID: 7734099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.